Lobbying Filing Details

Total Spending

$900,000

Activities

3

Lobbyists

4

Gov't Entities

12

Filing Information
Filing UUID:
ccf1d55a-b2e2-4a3e-b698-3ba451bd2743
Type:
Q4 - 4th Quarter - Report
Period:
2015 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 20, 2016 at 6:45 PM
Income:
$0
Expenses:
$900,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Debra S. Barrett, Senior Vice President for Global Government Affairs and Public Policy
Registrant
TEVA PHARMACEUTICALS USA, INC.
Parsippany, New Jersey
Client
TEVA PHARMACEUTICALS USA INC
New Jersey, United States of America
Lobbying Activities (3)
Activity 1
Copyright/Patent/Trademark

Patent reform proposals.

Foreign Entity Issues: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, has an interest in the issues listed above.

Lobbyists (4)
  • DEBRA BARRETT
  • ROBERT FALB
  • GRANT ERDEL
  • SUSIE AHN
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
Activity 2
Pharmacy

Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; FY 2016 Labor, HHS & Related Agencies Appropriations; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Section 505(b)(2) new drug applications and exclusivity period; and drug pricing proposals and issues.

Foreign Entity Issues: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed.

Lobbyists (4)
  • DEBRA BARRETT
  • ROBERT FALB
  • GRANT ERDEL
  • SUSIE AHN
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)
Activity 3
Trade (domestic/foreign)

Trans-Pacific Partnership Trade Agreement; Trans-Atlantic Trade & Investment Partnership Agreement.

Foreign Entity Issues: Teva Pharmaceutical Industries Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed.

Lobbyists (2)
  • DEBRA BARRETT
  • GRANT ERDEL
Government Entities (4)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Food & Drug Administration (FDA)

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.